Model Number 8637-40 |
Device Problems
Filling Problem (1233); Battery Problem (2885)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/21/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a health care provider (hcp) via a manufacturer representative regarding a patient with an implantable drug infusion pump indicated for intractable spasticity and post-spinal cord injury.The pump contained gablofen [2000 mcg/ml] at a dose of 200 mcg/day.It was reported during the procedure, they could not aspirate drug from the pump; there was no patient issue.There were no factors that might have led or contributed to the issue.They attempted with several different needles and even held pressure for several minutes thinking the reservoir valve might have sealed.Actions/interventions taken to resolve the issue included the drug was not aspirated, and new drug was obtained from the pharmacy.The pump was replaced on 2017-dec-21 and would be returned to the manufacturer for analysis.While attempting to aspirate the drug from the old pump, they were unable to do so despite numerous attempts.The issue was resolved at the time of the report.The patient¿s weight was unknown.The patient¿s status at the time of the report was alive ¿ no injury.No further patient complications were reported.
|
|
Manufacturer Narrative
|
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.The previously applied conclusion code is no longer applicable.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a healthcare provider via a company representative.At the pump replacement surgery, regarding the inability to aspirate, the printout showed 8 cc were in the pump¿s reservoir.It was further noted that the battery was depleted.No rotor study was performed.The patient recovered without sequela.The pump was returned to the manufacturer for analysis.
|
|
Manufacturer Narrative
|
Analysis of the pump (sn; (b)(4)) found reservoir access issues due to residue occurred before internal decontamination.Destructive analysis identified residue in the drug flow path.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received via a company representative.Regarding the battery previously having been reported as being depleted, it was clarified that the pump was replaced due to normal battery depletion.No diagnostic tests were needed regarding the battery depletion and it was further noted that elective replacement indicator (eri) was one month.The patient did not experience any symptoms regarding the initial reason for pump replacement being due to normal battery depletion.
|
|
Manufacturer Narrative
|
The initial report indicated adverse event and product problem which is no longer applicable.This field is now updated to indicate product problem only.The initial report indicated that intervention was required to prevent permanent impairment/damage.Regarding additional information received 2018-jan-18.This is no longer applicable as it was clarified the pump was initially being replaced due to normal battery depletion.The initial report indicated the type of reportable event was a serious injury which is no longer applicable.The type of report is now a reportable malfunction.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|